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臨床利用部門
教授 浜崎智仁（医学博士）
助教授 渡辺志朗（薬学博士）
助手 長津哲郎（薬学博士）
。研究目的
天然薬物の臨床利用を目指して， 1. n-3系脂肪酸の抗ストレス作用と抗炎症作用， 2.必須
脂肪酸欠之症の時に体内で積極的に合成されるアラキドン酸アナログであるミード酸の抗炎症作
用， 3.イソフラボノイドの一つ daidzinの抗酒効果
。研究概要
1. n-3系脂肪酸の一つ DHAの抗ストレス効果（敵意性制御効果）およびその作用機序を動
物モデルを用いて検討中である。 n四3の脂肪酸は普通経口投与して用いるが， n-3の静注に
よる各臓器の脂肪酸組成の変化について調べている。さらに，連続静注後の腹腔細胞からの
リピッドメディエーターの生産が低下するかを検討中である。
2. ミード酸の抗炎症作用の基礎的研究として，アイコサノイドの合成抑制程度，及びアレル
ギー性肺疾患への応用のための基礎研究を行っているO
3 . daidzinを含む大豆抽出物の抗酒効果を検討中。配糖体の方が効果が強いとの報告がある
ため，配糖体のまま吸収させる方法（エマルジョンにして口経投与）を検討している。
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。原著
1) Nakamura N., Hamazaki T., Jokaji H., Minami S.,and Kobayashi M.:Effects of 
HMG-CoA reductase inhibitors on plasma polyunsaturated fatty acid concentra-
tions in patients with hyperlipidemia. Int J Clin Lab Res, 28: 192-195, 1998. 
Abstract: We investigated the effect of 12 months' HMG-CoA reductase inhibitor treat-
ment on plasma polyunsaturated fatty acid concentrations in 19 patients with 
hyperlipidemia. Arachidonic acid concentrations were significantly increased following 
treatment (from 110.1士20.4 mg/l to 129.2土 31.6 mg/1, P<0.05). The ratio of 
eicosapentaenoic acid to arachidonic acid was significantly decreased at the end of 12 months' 
treatment (from 0. 702士0.370to 0.541士0.204,P<0.05). These results suggest that HMG-CoA 
reductase inhibitors may increase the synthesis of metabolites from arachidonic acid in pa-
tients with hyperlipidemia, and that the addition of fish oil is more effective for the preven-
tion of coronary heart disease than HMG-CoA reductase inhibitors alone. [6] reported that 
lovastatin, an HMG-CoA reductase inhibitor, increased arachidonic acid (AA) levels and 
thromboxane synthesis in human liver and monocytic cel lines in vitro. Thromboxane in 
duces platelet aggregation and vasoconstriction [7], and increased synthesis may cause 
thrombosis. In the present study, we examined the effect of 12 months' HMG-CoA reductase 
inhibitor treatment on plasma concentrations of polyunsaturated fatty acids (PUFA) in 
19 patients with hyperlipidemia. 
2) Nakamura N., Hamazaki T., Ohta M., Okubo K., Urakaze M., Sawazaki S., 
Yamazaki K., Satoh A., Temaru R., lshikura Y., Takata M., Kishida M.,and 
Kobayashi M.: Joint effects of HMG-CoA reductase inhibitors and 
eicosapentaenoic acids on serum lipid profile and plasma fatty acid concentrations 
in patients with hyperlipidemia. Int J Clin Lab Res, 29 : 22-25, 1999. 
Abstract: HMG COA reductase inhibitors reduce serum total cholesterol concentrations 
and the risk of coronary heart disease in patients with hypercholesterolemia. Recently, it has 
been reported that patients with combined hyperlipidemia are also at risk of coronary heart 
disease. However, HMG-CoA reductase inhibitor therapy alone does not sufficiently reduce 
serum triglyceride concentrations. Epidemiological and clinical evidence has shown that fish 
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oil can lower plasma lipid levels, especially triglycerides. Consequently, we investigated the 
effects ofthe combination of HMG-COA reductase inhibitors and eicosapentaenoic acid, a 
major component of fish oil, on hyper lipidemia. We administered 900 1,800 mg/day of the 
ethyl ester of eicosapentaenoic acid to patients with hyperlipidemia who had been treated 
with HMG-CoA reductase inhibitors for 30±6 months (means±SE). Serum total cholesterol 
and triglyceride concentrations were significantly decreased 3 months after the administra-
tion of eicosapentaenoic acid (from 5.63士0.23mmol/1 to 5.20±0.20 mmoljl, P<0.05; from 
2.07 ± 0.41 mmol/1 to 1.08 ± 0.17 mmol/1, P<0.01,respectively) .Serum high-density 
lipoproteincholesterol concentrations were significantly increased after the treatment (from 
1.23±0.12 mmoljl to 1.34士0.13mmoljl, P<0.05). Plasma eicosapentaenoic acid concentra-
tions and the ratio to arachidonic acid in plasma were also significantly increased 3 months 
after the treatment (from 101.9±8.lmg/l to 181.8±23.9mg/l, P<0.001; from 0.640±0.075 to 
1.211±0.170, P<0.001, respectively). These results suggested that the combination therapy of 
HMG CoA reductase inhibitors and eicosapentaenoic acid was effective for patients with 
hyper lipidemia. 
3）’Taki H., Sakai E., Sugiyama T., Mino T., Kuroda A.，’Taki K., Hamazaki T., 
Koizumi H.,and Kobayashi M.: Monokine stimulation of interleukin-11 production 
by human vascular smooth muscle cells in vitro. Atherosclerosis, 144: 375-380, 1999. 
Abstract: Human vascular smooth muscle cells (VSMC) are a component of blood vessels, 
and secrete a variety of cytokines in atherosclerotic loci. Interleukin-1 CIL-11), a member 
of IL-6-like cytokines, is reported to be involved in inflammation and tissue remodeling, both 
of which are observed in atherosclerosis. However, no information is available as to the pro-
duction of IL-11 by VSMC. Therefore, the expression of IL-11 in VSMC is investigated. The 
amounts of IL-11 protein and mRNA were determined by enzyme-linked immunosorbent 
assay (ELISA) and Northern blot analysis, respectively. The expression of IL-11 in VSMC 
was also immunohistochemically determined. IL-1α，transforming growth factor-P (TGF 
β） and, to a lesser extent, tumor necrosis factor α（TNFα） stimulated the IL-11 production 
by VSMC, and the stimulatory effects of IL-1αand TGF /3on IL-11 production were dose-
dependent. IL-1αand TNFαsynergistically augmented TGF /3stimulated IL 1 production 
by VSMC. Immunohistochemical staining also revealed the expression of IL-11 protein in 
VSMC. Furthermore, IL-1α，TGF /3, and TNFαinduced IL-11 gene expression in VSMC. 
Because IL-6-like cytokines are reported to be cytoprotective, monokine stimulated IL-llmay 
have a potent protective role in atherosclerotic lesions. 
4) Hamazaki T., Sawazaki S., Nagasawa T. Nagao Y., Kanagawa Y., and Yazawa K.: 
Administration of Docosahexaenoic Acid Influences Behavior and Plasma 
Catecholamine Levels at Times of Psychological Stress. Lipids, 34s: 33-37, 1999. 
Abstract: The purpose of the present research was to clarify the effect of docosahexaenoic 
acid (DHA) intake on behavior and plasma catecholamines (CA). In Study 1, 42 students 
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took either DHA-rich oil capsules containing 1.5-1.8 g DHA/d or control oil capsules contain-
ing 97% soybean oil plus 3% of another fish oil for 3 mon in a double-blind fashion. They took 
a psychological test (PF Study) at the start and end of the study. This study started at the 
end of summer vacation and ended just before the final exams. In the control group, external 
aggression (aggression against others) in PF Study was significantly increased at the end 
of the study as compared with that measured at the start ( +8.9%), whereas it was not signifi-
cantly changed in the DHA group (-1.0%). In a similar double-blind study (Study 2), we 
measured external aggression under nonstressful conditions. External aggression slightly 
decreased in the control group, whereas there were no significant changes in the DHA group. 
In Study 3 with 1 4 students, plasma CA were measured at the start and end of capsule ad-
ministration period of 2 mon. Subjects were under continuous stress of the final exams that 
lasted throughout the whole study period. The ratio of plasma epinephrine to norepinephrine 
concentrations was significantly increased in the DHA group (78%), whereas it stayed at the 
same level in the control group. In Study 4, mice were fed either DHA deficient diet or 
sufficient diet for 4 wk, and their rearing frequency (an anxiety index) was measured. In the 
DHA-su日icientgroup, the rearing frequency was significantly less than in the other group. 
These effects of DHA intake may be applied to people in an attempt to ameliorate stress-
related diseases. 
5) Sawazaki S., Hamazaki T., Yazawa K., and Kobayashi M.: The Effect of 
Docosahexaenoic Acid on Plasma Catecholamine Concentrations and Glucose 
Tolerance during Long-Lasting Psychological Stress: A Double-Blind Placebo-
Controlled Study.J Nutr Sci Vitaminol, 45: 655-665, 1999. 
Summary: We previously found that docosahexaenoic acid (DHA) intake prevented ag-
gression from increasing at times of mental stress. In the present study, we investigated 
whether DHA intake modified the plasma catecholamines and cortisol of medical students 
during a 9 wk period of final exams. We also investigated the effects of DHA intake on a 75g 
oral glucose tolerance test (oGTT). Fourteen medical students participated in the present 
study. They were randomly allocated to either control or DHA group in a double blind man-
ner. Subjects in the control group (4 males and 3 females) took 10 control capsules/d, each 
capsule containing 280 mg of mixed plant oil, and those in the DHA group (4 males and 3 fe-
males) took 10 DHA capsules/d containing 1.5 g DHA for 9 wk, during which subjects under-
went more than 20 stressful final exams. At the start and end of the study, plasma 
catecholamines (epinephrine, norepinephrine (NE) and dopamine) and cortisol were meas-
ured; a 75 g oGTT was also performed. There were no intra or intergroup differences in 
plasma glucose concentrations. However, NE concentrations were significantly reduced after 
DHA administration （ー 31%,p < 0.03). The other catecholamines and cortisol did not change 
significantly. The plasma ratio of epinephrine to NE increased in every DHA subject ( + 78%, 
p < 0.02), and intergroup differences were significant (p <0.03). We conclude that these ef-
fects of DHA may be applied to people under long-lasting psychological stress to prevent 
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stress-related diseases. 
6) Yasuda S., Watanabe S., Kobayashi T., Hata N., Misawa Y., Utsumi H., and 
Okuyama H.: Dietary Docosahexaenoic Acid Enhances Ferric Nitrilotriacetate-
Induced Oxidative Damage in Mice but not when Additional α－Tocopherol is 
Supplemented . Free Rad.Res., 30 : 199-205, 1999. 
Abstract : Weaning mice were fed a diet supplemented with beef tallow (BT) or BT plus 
docosahexaenoic acid (DHA) containing 100 mgα － tocopherol/kg （α－ToclOO) or 500 mg 
α－ tocopherol/kg （α－Toc500) for 4 wk to modify membrane fatty acid unsaturation, and 
then were administered ferric nitrilotriacetate (Fe-NTA). The mortality caused by Fe-NTA 
was higher in the group fed the DHA （α－ToclOO) diet than in the BT diet groups but the 
DHA （α－Toc500) diet suppressed this increase. Serum and kidney α－tocopherol contents 
were slightly influenced by the dietary fatty acids but not significantly. These results indi-
cate that the increased unsaturation of tissue lipids enhances oxidative damage induced by 
Fe-NTA in mice fed DHA （α－ToclOO) but not when additional α－tocopherol is supple-
mented, The apparent discrepancy between the observed enhancement by dietary DHA of 
oxidative damage and the beneficial effects of dietary DHA on the so-called free radical dis-
eases is discussed in terms of strong bolus oxidative stress and moderate chronic oxidative 
stress. 
7) Oh-hashi K., Takahashi T., Tanabe A., Watanabe S.,and Okuyama H.: Dietary α－ 
Linolenate Suppresses Endotoxin-Induced Platelet-Activating Factor Production 
in Rat Kidney.Lipids 34, 31-37, 1999. 
Abstract : In comparison with dietary high-linoleate safflower oil, high α－linolenate 
perilla oil decreased alkylacyl-and alkenylacyl-glycerophosphocholine (CPC) content in rat 
kidney by roughly 30 and 25%, respectively. The fatty acid composition was also modified by 
high α－linolenate oil; arachidonic acid (AA) level in alkylacyl-GPC, a platelet-activating fac-
tor (PAF) precursor, decreased by 30% along with concomitant increases in the n-3 fatty acid 
levels. P AF contents under resting conditions were similarly low in the two dietary groups. 
Fifteen minutes after endotoxin administration, PAF and lyso-PAF contents increased sig-
nificantly, and the PAF content in the high α－linolenate group was 60% lower than in the 
high linoleate group; the lyso-PAF contents also tended to be lower. Lyso-PAF 
acetyltransferase and CoA-independent transacylase activities in kidney microsomes in-
creased significantly after endotoxin administration, while PAF acetylhydrolase activity in 
the cytosol was relatively unchanged. The lyso-PAF acetyltransferase and PAF 
acetylhydrolase activities did not differ between the two dietary groups, but the CoA-
independent transacylase activity was roughly 30% lower in the high α－linolenate group. In 
agreement with in vitro study, our present study demonstrates that dietary high α－linole 
nate suppresses PAF production in rat kidney during systemic endotoxemia, and which is 
mainly due to the decrease in alkylacyl-GPC content, altered fatty acid compositions of the 
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precursor lipids and lower CoA-independent transacylase activity. 
8) Sato A., Osakabe T., Ikemoto A., Watanabe S., Kobayashi T., and Okuyama H.: 
Long-term n-3 Fatty Acid Deficiency Induces No Substantial Change in the Rate of 
Protein Synthesis in Rat. Brain and Liver. Biol. Pharm. Bull, 22: 775-779, 1999. 
Abstract: The influence of long-term n-3 fatty acid deficiency on the rate of protein syn-
thesis in rat brain and liver was investigated in relation to learning behavior or a presumed 
survival time-shortening factor (SSF) in rapseed oil, using a large-dose [3Hlphenylalanine 
(Phe) injection method. When Wistar rats were made n-3 fatty acid-deficient by feeding a 
safflower oil （α－linolenate-deficient) diet for 2 generations, conditions under which the saf-
flower oil group had been shown to exhibit altered learning behaviors, compared with the 
perilla oil group, no significant changes in the rate of protein synthesis were observed com-
pared with the perilla oil （α－linolenate sufficient) or rapeseed oil （α－linolena te-suf ficien t 
but SSF-containing) groups. However, the rapeseed oil group had a reduced specific radioac-
tivity of free Phe in the cerebral cortex, compared with the safflower oil group. In contrast 
to the reported observation of very long-term n-3 fatty acid deficiency inducing an almost 2-
fold increase the rate of protein synthesis in the brain, our results indicate that altered 
learning behavior resulting from n-3 fatty acid deficiency in rats is not associated with any 
substantial changes in the rate of protein synthesis in the brain. 
9) Ikemoto A., Kobayashi T., Emoto K., Umeda M., Watanabe S., and Okuyama H.: 
Effects of Docosahexaenoic and Arachidonic Acids on the Synthesis and 
Distribution of Aminophospholipids during Neuronal Differentiation of PC12 
Cells. Archives of Biochemistry and Biophysics. 364: 67-74, 1999. 
Abstract: We have shown previously that docosahexaenoic acid (DHA) promotes and 
arachidonic acid (AA) suppresses neurite outgrowth of PC12 cells induced by nerve growth 
factor (NGF) and that incorporation of [3H]ethanolamine into phosphatidylethanolamine 
(PE) is suppressed in PC12 cells by AA while DHA has no effect. In the present study, the 
effects of these fatty acids on PE synthesis via decarboxylation of phosphatidylserine (PS), 
another pathway of PE synthesis, and distribution of aminophospholipids were examined. 
Incorporation of [3H]serine into PS and PE was elevated in the course of NGF-induced differ-
entiation and was further stimulated significantly by DHA, but not by AA. 
[3H]Ethanolamine uptake by PC12 cells was significantly suppressed by AA but not by DHA 
while these fatty acids did not affect [3H]serine uptake, indicating that the suppression by 
AA of [3H]ethanolamine incorporation into phosphatidylethanolamine is attributable, at 
least in part, to a reduction in [3H]ethanolamine uptake. The distribution of PE in the outer 
leaflet of plasma membrane decreased during differentiation, which is known to be accompa-
nied by an increase in the surface area of plasma membrane. Supplementation of PC12 cels 
with DHA or AA did not affect the distribution of aminophospholipids. Thus, DHA and AA 
affected aminophospholipid synthesis and neurite outgrowth differently, but not the 
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transport and distribution of aminophospholipids, while the PE concentration in the outer 
leaflet of the plasma membrane decreased in association with morphological changes in PC12 
cels induced by NGF. 
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2) Hamazaki T.:The Control of Hostility by Fish Oil. The 3rd International Symposium 
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29 31，徳島．
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伝子の発現に対する食用油およびDHAの影響：日本薬学会第119年会 1999,3, 29-31. 
徳島．
7 ）池本敦，大石昌代，山本東，渡辺志朗，奥山治美： n-3系列脂肪酸欠之食によるラットの
学習能低下および脳内神経伝達物質含量に及ぼすDHA強化食の影響：日本薬学会第119
年会 1999,3, 29 31.徳島．
8）金川祐子，渡辺志朗，浜崎智仁：マウスの場慣れ行動に及ぼすDHA給餌の影響：日本脂
質栄養学会 1999,9,9.福山．
9 ）長津哲郎，浜崎智仁：マウスの岐み付き行動に及ぼすDHA摂取の影響：日本脂質栄養学
会 1999,9,9.福山．
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。その他
1）浜崎智仁：「DHA関連記事J1999 2.共同通信加盟各紙19件．
2）浜崎智仁：「DHAの有効活用探るJ1998,6,2.富山新聞．
3）浜崎智仁：科学「心身の疾患抑える魚油」 1999,5,25.北日本新聞．
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6 ）浜崎智仁：和漢の窓から「油の栄養学」 1999,10,2.読売新聞．
7）浜崎智仁：夢中人「講義活性化のアイデア論文に」 1999,12,3.朝日新聞．
8）浜崎智仁：「油の栄養学」 2000,1,L薬日新聞
。講演
1）浜崎智仁：「DHAによる敵意性の制御」食品新素材協議会， 1999,3,12.東京．
2）浜崎智仁：「EPA・DHAの健康に及ぼす影響」都城市医師会， 1999,3,19.都城．
3 ）浜崎智仁：特別講演「高脂血症治療の実践的な考え方」羽咋市医師会， 1999,5,28.羽咋．
4）浜崎智仁：「魚油と精神障害の治療JIfia Japan’99，食品化学新聞社， 1999,6,4.東京．
5）浜崎智仁：「油と健康」婦中町保健センター， 1999,7,13.富山．
6）浜崎智仁：抗酒効果をもっ和漢薬について．和漢研夏期セミナー1999.8.富山．
7）浜崎智仁：「油の栄養学：どんな油を取ったらいいか」市民公開講座， 1999,10,17.富山．
8）浜崎智仁：「魚と健康」全国魚食普及担当者育成検討会，大日本水産会， 1999,10,18.東京．
9）浜崎智仁：「健康食品は本当に万能か」砺波市民大学・学遊塾， 1999,10,27.砺波市教育
委員会，富山．
10）浜崎智仁：「機能性油脂による疾病予防と臨床での応用」機能性油脂の最新応用技術セミ
ナー， 1999,11,30.食品化学新聞社，東京．
11）浜崎智仁： （予定）「魚油の最新の知見 その行動と精神障害」磐周・磐田医師会，
2000,2,18.静岡．
12）浜崎智仁： （予定）「魚の油と心の落ち着き」東社協給食研究会 給食担当講習会，
2000,2,23.東京都社会福祉協議会，東京．
。共同研究
Alice Thienprasert：シルパコーン大学，「老齢者での DHAの敵意性に対する効果」 1998,7 
2000 3. 
。非常勤講師
浜崎智仁：富山女子短期大学食物栄養学科講義「臨床栄養学」 1999,6,28.富山．
。研究費取得状況
1）科学技術庁科学技術振興調整費（代表：浜崎智仁） ：「老齢者の敵意性抑制効果を有する
食品成分の探索」（第3年度） 18, 781千円
2）富山県受託研究費「和漢薬・バイオテクノロジー研究」（分担：浜崎智仁），「生体防御に
有効な和漢薬の開発研究J,434千円
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3 ）科学研究費補助金（奨励研究（A)) （代表：渡辺志朗），「食餌n-3系不飽和脂肪酸が・型
糖尿病に及ぼす影響とその機構の解析」， 1,600千円
4）平成1年度富山第一銀行奨学財団（代表：渡辺志朗） ：「エイコサペンタエン酸及びドコ
サヘキサエン酸乳剤の新規臨床利用法の開発に関する基礎的研究」， 400千円
5）国際研究集会派遣研究費旅費（浜崎智仁） ：「w6及び、w3系脂肪酸の必須性に関するワー
クショップ（ベセスダ，米国）J
。研究室在籍者
学部4年生 ：金田智子，橋本佳之
大学院前期 1年：道志勝，山崎裕洋，浜崎日奈
大学院前期2年：金川祐子
事務補佐員 ：浜谷裕子
